Updated Jul 16, 2026
Jenkins John Kenneth has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $38K.
John Kenneth Jenkins is a corporate insider associated with Corbus Pharmaceuticals Holdings, Inc., appearing in the company's SEC filings as of May 21, 2026. The provided context does not specify his exact role (e.g., director, officer, or other insider) within Corbus. Corbus Pharmaceuticals is a biotechnology company focused on cannabinoid-based therapeutics.
| Role | Insider |
|---|---|
| Notability | 45/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-11 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | S — Open-market sale | 4.8K | $7.91 | $38K |
| 2026-05-21 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | A — Grant or award | 3.8K | $0.00 |
John Kenneth Jenkins is a corporate insider associated with Corbus Pharmaceuticals Holdings, Inc., appearing in the company's SEC filings as of May 21, 2026. The provided context does not specify his exact role (e.g., director, officer, or other insider) within Corbus. Corbus Pharmaceuticals is a biotechnology company focused on cannabinoid-based therapeutics.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($38K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Jenkins John Kenneth profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.